Abstract 2797: AMG 511, a potent and selective class I PI3K inhibitor, demonstrates anti-tumor activity in multiple xenograft models
Year: 2012
Type: conference-abstract
Source: Cancer Research
Authors: Nancy Zhang, Sean Caenepeel, Ling Wang, Mark Norman, Richard Kendall, Terri Burgess, Robert Radinsky, Paul Hughes, Daniel J. Freeman
Institution: Amgen (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1966789767